Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 6-Month Safety Study of QuickShot Testosterone Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism

Next Previous
Search
Trial Profile

A 6-Month Safety Study of QuickShot Testosterone Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Testosterone enanthate (Primary)
  • Indications Hypogonadism
  • Focus Adverse reactions; Registrational
  • Acronyms STEADY
  • Sponsors Antares Pharma

    • Most Recent Events

    • 09 Nov 2018 According to an Antares Pharma media release, data from this trial will be presented as a moderated poster presentation at the 24th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America (SMSNA).
    • 09 Nov 2018 Results presented in an Antares media release.
    • 01 Oct 2018 According to an Antares Pharma media release, XYOSTED injection (once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot auto injector) has been approved by the U.S. Food and Drug Administration for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top